The Molecular Basis for Anti-Proteolytic and Non-Proteolytic Functions of Plasminogen Activator Inhibitor Type-1: Roles of the Reactive Centre Loop, the Shutter Region, the Flexible Joint Region and the Small Serpin Fragment

Citations Over TimeTop 10% of 2002 papers

Abstract

The serine proteinase inhibitor plasminogen activator inhibitor type-1 (PAI-1) is the primary physiological inhibitor of the tissue-type and the urokinase-type plasminogen activator (tPA and uPA, respectively) and as such an important regulator of proteolytic events taking place in the circulation and in the extracellular matrix. Moreover, a few non-proteolytic functions have been ascribed to PAI-1, mediated by its interaction with vitronectin or the interaction between the uPA-PAI-1 complex bound to the uPA receptor and members of the low density lipoprotein receptor family. PAI-1 belongs to the serpin family, characterised by an unusual conformational flexibility, which governs its molecular interactions. In this review we describe the anti-proteolytic and non-proteolytic functions of PAI-1 from both a biological and a biochemical point of view. We will relate the various biological roles of PAI-1 to its biochemistry in general and to the different conformations of PAI-1 in particular. We put emphasis on the intramolecular rearrangements of PAI-1 that are required for its antiproteolytic as well as its non-proteolytic functions.

Related Papers

• → The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion(1999)159 cited
• → Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1(2019)29 cited
• → The vitronectin binding area of plasminogen activator inhibitor‐1, mapped by mutagenesis and protection against an inactivating organochemical ligand(2002)52 cited
• → Redirection of the reaction between activated protein C and a serpin to the substrate pathway(2007)13 cited
• → Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type‐1(2001)49 cited